CIA
MESO

Concurrent Investment Advisors’s Mesoblast MESO Stock Holding History

Concurrent Investment Advisors’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,000
Closed -$161K – 1828
2025
Q3 		$161K Buy
+10,000
New +$146K ﹤0.01% 1384

Other funds holding MESO

Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Concurrent Investment Advisors's MESO Position: Q4 2025 in Review

Concurrent Investment Advisors sold out of Mesoblast (MESO) in Q4 2025, closing a stake of 10,000 shares — an estimated $161K sold.

Concurrent Investment Advisors first reported a position in MESO in Q3 2025 and held it in 1 quarter. The position peaked at $161K in Q3 2025. 74 funds tracked by Wall St. Rank hold MESO as of Q4 2025.

  • Concurrent Investment Advisors reported no remaining Mesoblast position as of Q4 2025 after selling out during the quarter.
  • Concurrent Investment Advisors sold 10,000 Mesoblast shares in Q4 2025, an estimated $161K.
  • Concurrent Investment Advisors first reported a position in Mesoblast in Q3 2025 and held it in 1 quarter.
  • Concurrent Investment Advisors's Mesoblast position peaked at $161K in Q3 2025.
  • 74 funds tracked by Wall St. Rank held Mesoblast as of Q4 2025.

Based on Concurrent Investment Advisors's 13F filing for Q4 2025, filed 29 Jan 2026.